The All Ordinaries index has pushed back above its 200-day simple moving average in recent sessions, holding the move with a close at 9,181.80, up 0.17%as bulls regained control of the medium-term technical narrative and positioned for a potential golden cross that could signal the start of a sustained uptrend.

The All Ords index retested appetite around the psychologically important 9,200 level during intraday trading before settling just below, with breadth telling a more bullish story than the headline number suggested. 268 shares ended the day in positive territory, against just 168 decliners, a ratio of roughly 1.6-to-1 in favour of gainers, indicating broad-based buying appetite rather than narrow leadership from a handful of mega-caps.

Evolution Mining emerged as the standout performer in the ASX 200, surging 9.55 percent to $14.45 on volume of nearly 11 million shares. The $29 billion gold producer’s rally, which extends its 12-month gain to 76 percent, underscored renewed appetite for the company on the back of record cash generation.

Beyond the large-cap space, risk appetite was even more pronounced.

 

Top Australian Brokers

Orthocell rocketed 24.14 percent to $1.08, adding $293 million in market capitalisation despite trading more than 25 percent below its level from a year ago. Titomic jumped 18 percent to $0.295, while EchoIQ gained 13.89 percent to $1.025, extending its extraordinary 12-month rally of 266 percent. Nufarm, an agricultural chemicals company that has struggled over the past year with a 35.51 percent decline, bounced 11.26 percent to $2.47, suggesting value hunters are circling beaten-down cyclicals.

Is a Golden Cross on the cards?

The technical setup has improved markedly over the past week. The All Ordinaries has not only reclaimed its 200-day moving average but is now watching as the 50-day SMA approaches from below. Should the shorter-term average cross above the longer-term one, in a pattern known as a golden cross, it would represent a classic trend-following buy signal and confirm that the recent correction has likely ended.

Market leadership today skewed heavily toward high-beta growth, medtech and biotech innovators, and small-cap resource plays. Alongside Orthocell’s surge, Artrya climbed 10.10 percent to $4.25, building on a remarkable 534 percent gain over the past year. Andean Silver added 10.45 percent to $2.22, while Torque Metals rose 10 percent to $0.55 after posting a 478.95 percent 12-month return.

The pattern of leadership is characteristic of markets transitioning from a corrective phase back into an uptrend, as when markets are willing to pay up for high-beta exposure and chase momentum in already-strong names, it typically signals improving risk appetite rather than defensive positioning.

Selective Weakness

Looking at the other side of the divide, the laggards on the day were led by Energy Resources of Australia, down 12.50 percent to $0.0035, though the penny-stock level magnifies percentage moves and the company still trades 75 percent higher than a year ago. Boss Energy fell 9.28 percent to $1.565, extending its 12-month decline to nearly 40 percent and highlighting ongoing concerns in select uranium names around project economics and sector sentiment.

Lynas Rare Earths dropped 6.84 percent to $20.56 despite posting a 156 percent gain over the past year, suggesting profit-taking after a strong run. EQ Resources slipped 5.97 percent to $0.315, trimming a portion of its extraordinary 632 percent 12-month rally as markets rotated away from over-extended positions.

The concentration of weakness in prior big winners and a handful of structurally challenged resource names fits the pattern of a healthy bull market rotation. Markets are pruning the most extended positions and idiosyncratic disappointments, not engaging in systematic de-risking.

Outlook and Analysis

The technical picture now hinges on whether the All Ordinaries can hold above its 200-day moving average and consolidate near or above the 9,200 level. A sustained break above that threshold, combined with confirmation of the golden cross, would increase the probability of a renewed bull leg higher, particularly if macroeconomic data remain benign and global commodity prices stay supportive.

The breadth and character of the session, with more than 60 percent of stocks advancing on a day when the index only gained 0.17 percent, suggests the bid is broad and durable rather than concentrated in a few index heavyweights. That type of “under the surface” strength is typically more sustainable than narrow rallies driven by defensive positioning or mega-cap outperformance.

However, the dominance of micro-caps and multi-baggers on the leader board also carries a late-cycle flavour. When speculative names and already-strong momentum plays command the top of the performance table, it can signal that the easy money has been made and fragility is building beneath the surface. Any negative macro shock; whether from interest rates, commodity prices, Chinese economic data, or geopolitical developments, could derail the golden-cross setup and send the index back to test previous levels.

The Bull Team
The Bull Team is a group of finance writers and journalists that provide commentary and insights on the Australian stock market and beyond.